KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Guardant Health (GH) Leases (2017 - 2025)

Guardant Health's Leases history spans 9 years, with the latest figure at $158.8 million for Q4 2025.

  • For Q4 2025, Leases rose 11.66% year-over-year to $158.8 million; the TTM value through Dec 2025 reached $158.8 million, up 11.66%, while the annual FY2025 figure was $158.8 million, 11.66% up from the prior year.
  • Leases for Q4 2025 was $158.8 million at Guardant Health, down from $163.5 million in the prior quarter.
  • Across five years, Leases topped out at $205.7 million in Q1 2021 and bottomed at $140.5 million in Q1 2025.
  • The 5-year median for Leases is $167.5 million (2023), against an average of $169.5 million.
  • The largest annual shift saw Leases soared 582.57% in 2021 before it decreased 11.59% in 2024.
  • A 5-year view of Leases shows it stood at $189.4 million in 2021, then fell by 8.15% to $174.0 million in 2022, then dropped by 9.42% to $157.6 million in 2023, then decreased by 9.74% to $142.3 million in 2024, then grew by 11.66% to $158.8 million in 2025.
  • Per Business Quant, the three most recent readings for GH's Leases are $158.8 million (Q4 2025), $163.5 million (Q3 2025), and $169.8 million (Q2 2025).